Cell Source Semi Variance
| CLCS Stock | | | USD 0.76 -0.01 -1.30% |
The Semi Variance profile for Cell Source is based on historical price and volume observations. Related screening structures are referenced through
Equity Screeners. Cell Source has a market cap of 10.61 M, current ratio of 0.03. Portfolio-level context is available through
Trending Equities. Cell Source can be added to a watchlist or portfolio for position tracking. Position weights are derived from the selected portfolio construction methodology. Broader economic conditions can influence Cell Source's company valuation — related indicators include
signals in discontinued.
Cell Source has current Semi Variance of 16.42. Semi-variance provides a good measure of downside volatility for equity or a portfolio. It is similar to variance, but it only looks at periods where the returns are less than the target or average level.
Semi Variance | = | SUM(RET DEV)2N(ZERO) |
| = | 16.42 | |
| SUM | = | Summation notation |
| RET DEV | = | Actual return deviation over selected period |
| N(ZERO) | = | Number of points with returns less than zero |
Semi Variance Peers Comparison
Semi Variance Relative To Other Indicators
Cell Source maintains a
third standing in semi variance relative to competitors. It is currently under evaluation in maximum drawdown relative to competitors yielding
1.98 of Maximum Drawdown per Semi Variance. For Cell Source, Maximum Drawdown stands at
1.98 times Semi Variance
Semi-variance is the square of semi-deviation. Semi-variance is calculated by averaging the deviations of returns that have a result that is less than the mean.
Compare Cell Source to Peers
Other Technical Indicators